Pfizer’s antiviral COVID-19 pill shows promise

Pfizer released preliminary clinical trial results for its antiviral pill, showing an 89 per cent reduction in risk of hospitalization or death in patients with COVID-19 symptoms.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting